ATE386814T1 - Gemischte g-proteinzusammensetzung und ihre verwendung - Google Patents
Gemischte g-proteinzusammensetzung und ihre verwendungInfo
- Publication number
- ATE386814T1 ATE386814T1 AT97932210T AT97932210T ATE386814T1 AT E386814 T1 ATE386814 T1 AT E386814T1 AT 97932210 T AT97932210 T AT 97932210T AT 97932210 T AT97932210 T AT 97932210T AT E386814 T1 ATE386814 T1 AT E386814T1
- Authority
- AT
- Austria
- Prior art keywords
- mixed
- protein composition
- activation
- compositions
- protein
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 108091006027 G proteins Proteins 0.000 abstract 2
- 102000030782 GTP binding Human genes 0.000 abstract 2
- 108091000058 GTP-Binding Proteins 0.000 abstract 2
- 230000004913 activation Effects 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 abstract 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 230000019491 signal transduction Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
- C12N2830/003—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor tet inducible
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2023496P | 1996-06-21 | 1996-06-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE386814T1 true ATE386814T1 (de) | 2008-03-15 |
Family
ID=21797473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97932210T ATE386814T1 (de) | 1996-06-21 | 1997-06-20 | Gemischte g-proteinzusammensetzung und ihre verwendung |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US6004808A (de) |
| EP (1) | EP1012324B1 (de) |
| AT (1) | ATE386814T1 (de) |
| AU (1) | AU3572897A (de) |
| CA (1) | CA2281898C (de) |
| DE (1) | DE69738528D1 (de) |
| WO (1) | WO1997048820A1 (de) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6025485A (en) | 1997-02-14 | 2000-02-15 | Arcaris, Inc. | Methods and compositions for peptide libraries displayed on light-emitting scaffolds |
| US5955275A (en) * | 1997-02-14 | 1999-09-21 | Arcaris, Inc. | Methods for identifying nucleic acid sequences encoding agents that affect cellular phenotypes |
| US6623922B1 (en) | 1997-02-14 | 2003-09-23 | Deltagen Proteomics | Methods for identifying, characterizing, and evolving cell-type specific CIS regulatory elements |
| US5985584A (en) * | 1997-02-19 | 1999-11-16 | American Cyanamid Company | Method to identify plant proteins that function in G protein coupled systems and compositions therefor |
| US6759206B1 (en) | 1997-02-27 | 2004-07-06 | Cellomics, Inc. | System for cell-based screening |
| US7853411B2 (en) * | 1997-02-27 | 2010-12-14 | Cellomics, Inc. | System for cell-based screening |
| US7087388B1 (en) * | 1997-07-15 | 2006-08-08 | Aurora Biosciences Corporation | Compositions and methods for identifying modulators of transducisomes, a new class of therapeutic targets |
| US7262280B1 (en) | 1998-04-03 | 2007-08-28 | Nps Pharmaceuticals, Inc. | G-protein fusion receptors and constructs encoding same |
| IL138747A0 (en) * | 1998-04-03 | 2001-10-31 | Nps Pharma Inc | G-protein fusion receptors and chimeric gabab receptors |
| US6692696B1 (en) * | 1998-06-18 | 2004-02-17 | ARETé ASSOCIATES | Biosensor |
| DE19860833C1 (de) * | 1998-12-30 | 2000-09-07 | Albrecht E Sippel | Methode zur zellulären High-Throughput(Hochdurchsatz)-Detektion von Rezeptor-Liganden-Interaktionen |
| US20020031802A1 (en) * | 2000-05-12 | 2002-03-14 | Yi Hu | Novel seven transmembrane proteins and polynucleotides encoding the same |
| US6929925B1 (en) | 1999-01-27 | 2005-08-16 | The Regents Of The University Of California | Assays for sensory modulators using a sensory cell specific G-protein beta subunit |
| WO2000045179A2 (en) * | 1999-01-27 | 2000-08-03 | The Regents Of The University Of California | Screening for modulators of g-protein subunit beta 3 |
| US7067277B1 (en) | 1999-12-23 | 2006-06-27 | H. Lundbeck A/S | Chimeric G proteins and uses thereof |
| EP1143013A1 (de) | 2000-04-03 | 2001-10-10 | Warner-Lambert Company | Verfahren und Zusammenzetzungen zur Screening von ICRAC-Modulatoren |
| EP1143017A3 (de) * | 2000-04-03 | 2004-01-28 | Warner-Lambert Company LLC | Methoden und Zusammensetzungen zum Screenen von icrac Modulatoren |
| US7264926B2 (en) * | 2000-04-18 | 2007-09-04 | Millennium Pharmaceuticals, Inc. | Nucleoside Phosphatase |
| CA2405504A1 (en) | 2000-04-24 | 2001-11-15 | Wyeth | Transgenic animal |
| WO2001081411A2 (en) * | 2000-04-27 | 2001-11-01 | Lexicon Genetics Incorporated | Human 7-transmembrane g-protein coupled receptors and polynucleotides encoding the same |
| DE10033353A1 (de) * | 2000-07-08 | 2002-01-24 | Aventis Pharma Gmbh | Breit einsetzbares Verfahren zur Identifizierung von Modulatoren von G-Protein gekoppelten Rezeptoren |
| AU2001296965A1 (en) * | 2000-09-22 | 2002-04-02 | The Johns Hopkins University School Of Medicine | A method of use of sonic hedgehog protein as a ligand for patched |
| WO2002036622A2 (en) * | 2000-10-30 | 2002-05-10 | Senomyx, Inc. | GαqPROETIN VARIANTS AND THEIR USE IN THE ANALYSIS AND DISCOVERY OF AGONISTS AND ANTAGONISTS OF CHEMOSENSORY RECEPTORS |
| WO2002068473A1 (en) * | 2001-02-08 | 2002-09-06 | Temple University-Of The Commonwealth System Of Higher Education | Biosensor for detecting chemical agents |
| US20100248268A1 (en) * | 2001-03-27 | 2010-09-30 | Woods Daniel F | Methods to utilize invertebrate chemosensory proteins for industrial and commercial uses |
| US20030165879A1 (en) * | 2001-03-27 | 2003-09-04 | Woods Daniel F. | Efficient methods for isolating functional G-protein coupled receptors and identifying active effectors and efficient methods to isolate proteins invovled in olfaction and efficient methods to isolate and identifying active effectors |
| US20070003980A1 (en) * | 2001-03-27 | 2007-01-04 | Woods Daniel F | Efficient methods to isolate effectors of proteins involved in olfactory or chemosensory pathways and efficient methods to use these effectors to alter organism olfaction, chemosensation, or behavior |
| EP1572871A4 (de) * | 2001-04-20 | 2007-11-14 | Sinai School Medicine | T1r3, ein neuer geschmacksrezeptor |
| US7803982B2 (en) | 2001-04-20 | 2010-09-28 | The Mount Sinai School Of Medicine Of New York University | T1R3 transgenic animals, cells and related methods |
| MXPA03011260A (es) * | 2001-06-07 | 2004-02-27 | Wyeth Corp | Receptor acoplado a proteina g y usos del mismo. |
| CN100489102C (zh) | 2001-06-26 | 2009-05-20 | 塞诺米克斯公司 | T1r异源寡聚的味觉受体和表达所述受体的细胞系及其在鉴定味觉化合物中的用途 |
| EP2354156A3 (de) | 2001-08-14 | 2011-11-16 | Sentigen Biosciences, Inc. | Nukleinsäuren und Proteine von Insekten OR83B-Duftrezeptorgenen und Verwendungen davon |
| US7208290B2 (en) * | 2001-12-14 | 2007-04-24 | Senomyx, Inc. | Methods of co-expressing umami taste receptors and chimeric Gα15 variants |
| US20050181464A1 (en) * | 2002-04-04 | 2005-08-18 | Affinium Pharmaceuticals, Inc. | Novel purified polypeptides from bacteria |
| DK1495330T3 (da) * | 2002-04-12 | 2009-05-18 | Brian F O'dowd | Fremgangsmåde til at identificere forbindelser, som påvirker transmembran-proteiner |
| AU2003261280B2 (en) * | 2002-07-29 | 2009-02-05 | Senomyx, Inc. | Identification of a novel bitter taste receptor, T2R76 |
| US20060019346A1 (en) * | 2002-07-29 | 2006-01-26 | Senomyx, Inc. | Identification of a novel bitter taste receptor T2R76 that specifically responds to brucine and prop bitter ligands |
| DE10256947A1 (de) * | 2002-12-05 | 2004-06-24 | Grünenthal GmbH | Verfahren zur Messung der Aktivität G(alpha)i- oder G(alpha)o-gekoppelter Rezeptoren mittels Ca2+-Influx in Zellen |
| EP1685379A4 (de) * | 2003-07-11 | 2007-07-11 | Merck & Co Inc | Verfahren zur identifizierung von zelloberflächen-rezeptorprotein-modulatoren |
| US8133733B2 (en) | 2003-10-24 | 2012-03-13 | Gencia Corporation | Nonviral vectors for delivering polynucleotides to target tissues |
| US20090123468A1 (en) | 2003-10-24 | 2009-05-14 | Gencia Corporation | Transducible polypeptides for modifying metabolism |
| US8507277B2 (en) | 2003-10-24 | 2013-08-13 | Gencia Corporation | Nonviral vectors for delivering polynucleotides |
| US8062891B2 (en) | 2003-10-24 | 2011-11-22 | Gencia Corporation | Nonviral vectors for delivering polynucleotides to plants |
| CA2543257C (en) | 2003-10-24 | 2013-12-31 | Gencia Corporation | Methods and compositions for delivering polynucleotides |
| WO2005042574A1 (en) * | 2003-11-03 | 2005-05-12 | Acadia Pharmaceuticals Inc. | High troughput functional assay for g-protein coupled receptors using a rap-ras chimeric protein |
| GB0421693D0 (en) | 2004-09-30 | 2004-11-03 | Amersham Biosciences Uk Ltd | Method for measuring binding of a test compound to a G-protein coupled receptor |
| US20070218456A1 (en) * | 2006-02-08 | 2007-09-20 | Invitrogen Corporation | Cellular assays for signaling receptors |
| US7998414B2 (en) * | 2007-02-28 | 2011-08-16 | Corning Incorporated | System for high throughput GPCR functional assay |
| ES2727516T3 (es) * | 2013-08-20 | 2019-10-16 | Meiji Seika Pharma Co Ltd | Métodos para evaluar y cribar agonistas del receptor de S1P1 |
| WO2016050441A1 (en) | 2014-10-02 | 2016-04-07 | Paul Scherrer Institut | HUMAN G PROTEIN ALPHA SUBUNIT Gxi1 WITH AT LEAST ONE MUTATED AMINO ACID RESIDUE |
| WO2019060316A1 (en) * | 2017-09-19 | 2019-03-28 | Cannametrix, Llc | CELL-BASED DETERMINATION FOR QUANTIFYING THE POWER AND EFFICACY OF CANNABINOIDS AND / OR TERPENOIDS, AND METHODS OF USE THEREOF |
| CA3090966A1 (en) * | 2018-02-20 | 2019-08-29 | Charite - Universitatsmedizin Berlin | Mc4r agonist efficacy in subjects with mc4r deficiencies and impaired nfat signaling |
| US12247244B2 (en) * | 2018-07-31 | 2025-03-11 | The University Of Tokyo | Membrane protein activity measurement method |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4703008A (en) * | 1983-12-13 | 1987-10-27 | Kiren-Amgen, Inc. | DNA sequences encoding erythropoietin |
| US4677195A (en) * | 1985-01-11 | 1987-06-30 | Genetics Institute, Inc. | Method for the purification of erythropoietin and erythropoietin compositions |
| US5266464A (en) * | 1988-02-10 | 1993-11-30 | Ict Pharmaceuticals, Inc. | Method of screening for protein inhibitors and activators |
| US5665543A (en) * | 1989-07-18 | 1997-09-09 | Oncogene Science, Inc. | Method of discovering chemicals capable of functioning as gene expression modulators |
| US5580722A (en) * | 1989-07-18 | 1996-12-03 | Oncogene Science, Inc. | Methods of determining chemicals that modulate transcriptionally expression of genes associated with cardiovascular disease |
| US5462856A (en) * | 1990-07-19 | 1995-10-31 | Bunsen Rush Laboratories, Inc. | Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins |
| US5401629A (en) * | 1990-08-07 | 1995-03-28 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Assay methods and compositions useful for measuring the transduction of an intracellular signal |
| US5273999A (en) * | 1991-09-10 | 1993-12-28 | Hoffmann-La Roche Inc. | Carboxylic acid leukotriene B4 antagonists |
| CA2120518C (en) * | 1991-10-01 | 1998-10-13 | Monika Konig | A method of identifying ligands and antagonists of ligands |
| WO1993025712A1 (en) * | 1992-06-15 | 1993-12-23 | The Regents Of The University Of California | Screening assay for the identification of immunosuppressive drugs |
| US5691188A (en) * | 1994-02-14 | 1997-11-25 | American Cyanamid Company | Transformed yeast cells expressing heterologous G-protein coupled receptor |
| US5741657A (en) * | 1995-03-20 | 1998-04-21 | The Regents Of The University Of California | Fluorogenic substrates for β-lactamase and methods of use |
-
1997
- 1997-06-19 US US08/878,801 patent/US6004808A/en not_active Expired - Lifetime
- 1997-06-20 AU AU35728/97A patent/AU3572897A/en not_active Abandoned
- 1997-06-20 EP EP97932210A patent/EP1012324B1/de not_active Expired - Lifetime
- 1997-06-20 DE DE69738528T patent/DE69738528D1/de not_active Expired - Lifetime
- 1997-06-20 WO PCT/US1997/010642 patent/WO1997048820A1/en not_active Ceased
- 1997-06-20 CA CA002281898A patent/CA2281898C/en not_active Expired - Fee Related
- 1997-06-20 AT AT97932210T patent/ATE386814T1/de not_active IP Right Cessation
-
2005
- 2005-09-16 US US11/228,364 patent/US20060008855A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20060008855A1 (en) | 2006-01-12 |
| CA2281898C (en) | 2007-03-20 |
| EP1012324A1 (de) | 2000-06-28 |
| AU3572897A (en) | 1998-01-07 |
| CA2281898A1 (en) | 1997-12-24 |
| EP1012324A4 (de) | 2003-08-13 |
| US6004808A (en) | 1999-12-21 |
| WO1997048820A1 (en) | 1997-12-24 |
| DE69738528D1 (de) | 2008-04-03 |
| EP1012324B1 (de) | 2008-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE386814T1 (de) | Gemischte g-proteinzusammensetzung und ihre verwendung | |
| ATE177535T1 (de) | Identifizierung von liganden durch selektive vermehrung von, durch rezeptoren tranzfizierten zellen | |
| ATE239912T1 (de) | Verfahren und vorrichtung zur referenzierung von fluoreszenzintensitätssignalen | |
| KR900702368A (ko) | 전기화학 발광성 분석 | |
| ATA28980A (de) | Beschichtungsmaterial fuer die rueckseiten von zu verklebenden papieren | |
| DE69822484D1 (de) | Methoden zur bestimmung der rezeptoraktivität und dafür verwendbare konstrukte | |
| NO875476D0 (no) | Elektrokjemiluminiscente proever. | |
| DK1423541T3 (da) | Fremgangsmåde til at bestemme multiple analytter | |
| ATE324462T1 (de) | Assays zur detektierung von modulatoren der cytoskeletalen funktion | |
| AU2023499A (en) | Pth receptor and screening assay utilizing the same | |
| DE69928250D1 (de) | Analytisches verfahren unter verwendung von multipelviren-markierung | |
| ZA912303B (en) | Protein partner screening assays and uses thereof | |
| ES2168310T3 (es) | Reactivos y metodos de deteccion y de cuantificacion de la testosterona en muestras de fluido. | |
| DE69941690D1 (de) | Methoden, testsätze und kompositionen zur detektion und quantifizierung von zielsequenzen | |
| TR199701469T1 (xx) | �i�man (OB) proteinin etkilerini de�i�tiren bile�imlerin meydana ��kar�lmas� i�in y�ntem. | |
| AU5326198A (en) | Synthetic biepitope compounds which can be used as standards in the biological assays of troponin I | |
| NO960715L (no) | Fremgangsmåter for sceening av anti-östrogen forbindelser | |
| SE9904660D0 (sv) | Novel assays | |
| EA200400024A1 (ru) | Новый сцинтилляционный анализ близкого расстояния для изучения связывающих аминогликозид молекул (abm) | |
| DE60022642D1 (de) | Identifizierung von liganden für "orphan"-rezeptoren unter verwendung von massenspektrometrie | |
| DE602004027737D1 (de) | Neue chemilumineszenzverbindungen und ihre verwendung | |
| DE69713138D1 (de) | Immuntestsystem zur bestimmung von vitamin d | |
| WO2003100078A3 (en) | Common ligand universal enzyme and compositions for use therein | |
| DE59902151D1 (de) | Verwendung von bisazoverbindungen enthaltenden zusammensetzungen als rissprüfmittel | |
| NO20004753L (no) | Fluorescent assay for topoisomerase-inhibitorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |